Search jobs 11-Jan-2021 Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
−
1, Representing 50% Growth from FY2019
−
Wave 1 Pipeline Portfolio Includes 12 New Molecular Entities Targeted for Launch by FY2024 Representing Best-in-Class/First-in-Class Therapies with Significant Market Potential
−
Rapid Deleveraging On Track to Achieve Target of 2x Net Debt / adjusted EBITDA within Fiscal Years 2021 to 2023
OSAKA, Japan & CAMBRIDGE, Mass. (BUSINESS WIRE) Takeda Pharmaceutical Company Limited
(TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, shared details on Takeda’s portfolio and pipeline strategy and financial outlook, including key programs expected
Takeda Pharmaceutical Company Limited
Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference
Tuesday, January 12, 2021 3:15PM IST (9:45AM GMT)
−
−
Wave 1 Pipeline Portfolio Includes 12 New Molecular Entities Targeted for Launch by FY2024 Representing Best-in-Class/First-in-Class Therapies with Significant Market Potential
−
Rapid Deleveraging On Track to Achieve Target of 2x Net Debt / adjusted EBITDA within Fiscal Years 2021 to 2023
Takeda Pharmaceutical Company Limited
(TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer, Christophe Weber, shared details on Takeda’s portfolio and pipeline strategy and financial outlook, including key programs expected to contribute to the company’s revenue growth over the ne
Adult COVID-19 patients currently in hospital: 60
Percent of adult inpatient beds occupied by COVID-19 patients: 14%
Available adult inpatient beds: 8
Adult COVID-19 patients currently in ICU: 31
Percent of adult ICU beds occupied by COVID-19 patients: 33%
Available adult ICU beds: 1
Texas Childrens Hospital
Percent of adult inpatient beds occupied by COVID-19 patients: 38%
Available adult inpatient beds: 82
Adult COVID-19 patients currently in ICU: 16
Percent of adult ICU beds occupied by COVID-19 patients: N/A
Available adult ICU beds: 0
University of Texas MD Anderson Cancer Center
Adult COVID-19 patients currently in hospital: 79
Percent of adult inpatient beds occupied by COVID-19 patients: 11%
Available adult inpatient beds: 234
Loading video.
VIDEO: JACR Deputy Editor-in-Chief Christoph I. Lee, MD, MS, and guest editor Reed A. Omary, MD, MS, discuss the JACR provocative special issue. view more
Credit: Journal of the American College of Radiology
Philadelphia, January 12, 2021 - A special issue of the
Journal of the American College of Radiology (JACR), published by Elsevier, challenges conventional wisdom across the imaging community. This collection of articles, the Provocative Issue, presents extreme opinions on pressing issues confronting radiologists with the deliberate aim of sparking positive dialog and debate that will lead to innovative solutions to improve patient care and imaging-related outcomes.
The issue is guest-edited by:
Oral Sex Partner Numbers, Initiation Timing Tied to Oropharyngeal Cancer Risk medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.